Avid Bioservices Inc (CDMO)

[biopharm]

I agree and initially when I thought Roche would be a good fit.... was clearly thinking selfishly with the highest amount a BP would pay for Peregrine. We can assum that Roche would want to be involved in the talks because they want to know what challenges lie ahead for them since they may not be the top bidder....but here is where we can see a bidding war because if Bavituximab is the next big cancer drug of need... atleast one BP will want to corner the cancer market and we will see a price tag that will reward us longs